The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions
Crohn's DiseasePerianal Fistulas
Interventions
OTHER

Hyperbaric oxygen

HBOT will be given for 40 sessions of 2 atmospheres for 90 minutes each session, 5 times a week (2 months). TNF alpha blocker therapy will remain the treatment received before recruitment.

Trial Locations (1)

70800

The institute of gastroenterology and liver disease, Assaf Harofe Medical Center, Ẕerifin

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT01828190 - The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers | Biotech Hunter | Biotech Hunter